Dietary fat, visceral fat depots and aging
Dietary fat, visceral fat depots and aging
批准号:
8041660
负责人:
MICHAL Mateusz MASTERNAK
金额:
$29.83万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2011-08-31
中文摘要
描述(由申请人提供):我们研究的长期目标是确定内脏脂肪对胰岛素敏感性和寿命的影响。在上个世纪,医疗保健的改善显著提高了发达国家的平均寿命。随着老年人口的增长,医生正在治疗更多患有与年龄有关的疾病的患者。代谢综合征、动脉粥样硬化疾病、胰岛素抵抗和糖尿病的发病率不断上升,在75岁以后的人群中,这些疾病的发病率从7%上升到近20%,这对全球医学界提出了挑战。影响胰岛素抵抗和糖尿病的两个有据可查的因素是缺乏体育活动和不健康的饮食,两者结合可能导致肥胖。对小鼠和大鼠的几项研究表明,肥胖会导致胰岛素抵抗,并对寿命产生负面影响。热量限制减少脂肪的体积,提高胰岛素敏感性和延长寿命。人们可以推断,一个瘦的身体促进健康的胰岛素作用和更长的寿命。然而,艾姆斯侏儒和GHRKO小鼠都对注射的胰岛素高度敏感,并且尽管脂肪体积增加或正常(取决于年龄),但寿命长。是什么调节了这些突变动物的高胰岛素敏感性和更长的寿命?我们假设Prop 1df突变和GHR敲除导致白色脂肪组织有益的改变,影响胰岛素敏感性和寿命。 在拟议的研究中,我们将研究高脂饮食(HFD)和内脏脂肪库对正常,艾姆斯侏儒和GHRKO小鼠的胰岛素信号和寿命的影响。我们认为,长寿的艾姆斯侏儒和GHRKO小鼠将抵抗HFD的不利影响。此外,根据我们的初步数据表明,与正常动物相比,内脏脂肪在GHRKO和艾姆斯侏儒小鼠的胰岛素信号调节中具有非常不同的、几乎相反的作用,我们提出内脏脂肪去除不会改善这些长寿突变体的胰岛素作用和寿命。 我们相信,这些研究将阐明内脏脂肪库和饮食对胰岛素信号和长寿的相互作用。目的1:分析内脏脂肪库切除术和基因型对GHRKO、艾姆斯侏儒和正常小鼠胰岛素信号、脂肪细胞因子、脂质代谢和寿命的交互作用。目标二:分析高脂饮食(HFD)对GHRKO、艾姆斯侏儒和正常小鼠的胰岛素信号传导、脂肪细胞因子、细胞因子、脂质和代谢的影响。目标3:通过将来自GHRKO的内脏脂肪移植到正常小鼠体内,确定在缺乏GH作用的情况下发育的内脏脂肪对体内胰岛素信号传导的功能。
公共卫生相关性:确定延长寿命和延迟衰老的机制和/或原因是21世纪世纪的重大科学挑战之一。这些机制是否涉及遗传、生活方式或饮食选择?如果人们能够确定其中的机制,未来的研究将有延长寿命和改善人类“健康寿命”的目标。
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of our research is to determine the effects of visceral fat on insulin sensitivity and longevity. Improvements in healthcare during the last century have significantly increased the average lifespan in developed countries. With the growing population of elderly, physicians are treating a greater number of patients suffering from age-related diseases. Growing incidence of metabolic syndrome, atherosclerotic disease, insulin resistance and diabetes mellitus-which jumps from 7% to almost 20% of the population after age 75-challenges the global medical community. Two well-documented factors affecting insulin resistance and diabetes are a lack of physical activity and an unhealthy diet, which may cause obesity when combined. Several studies with mice and rats indicated that obesity causes insulin resistance and has negative effects on longevity. Calorie restriction decreases the volume of fat, improves insulin sensitivity and extends longevity. One could infer that a lean body promotes healthy insulin action and a longer life. However, Ames dwarf and GHRKO mice are both hyper-sensitive to injected insulin and long-lived despite an increased or normal volume of fat (depending on age). What regulates high insulin sensitivity and longer lifespan in these mutant animals? We hypothesize that Prop1df mutation and GHR knockout cause beneficial alterations in white adipose tissue that influences insulin sensitivity and longevity. In the proposed studies, we will investigate effects of a high fat diet (HFD) and visceral fat depots on insulin signaling and longevity in normal, Ames dwarf and GHRKO mice. We propose that long-living Ames dwarf and GHRKO mice will be resistant to the detrimental effects of HFD. Also based on our preliminary data indicating a very different, nearly opposite role of visceral fat in the regulation of insulin signaling in GHRKO and Ames dwarf mice in comparison to normal animals, we propose that visceral fat removal will not improve insulin action and longevity of these long-lived mutants. We believe that these studies will elucidate the interaction of visceral fat depots and diet on insulin signaling and longevity. The following specific aims are proposed: Aim 1: Analyze the interactive effects of surgical removal of visceral fat depots and genotype on insulin signaling, adipocytokines, lipid metabolism and longevity in GHRKO, Ames dwarf and normal mice. Aim 2: Analyze the effects of a high fat diet (HFD) on insulin signaling, adipocytokines, cytokines, lipid and metabolism in GHRKO, Ames dwarf and normal mice. Aim 3: Determine the function of visceral fat developed in the absence of GH action on insulin signaling in vivo by transplanting visceral fat from GHRKO into normal mice.
PUBLIC HEALTH RELEVANCE: Identifying the mechanisms and/or causes of extended longevity and delayed aging is one of the great scientific challenges of the 21st century. Do these mechanisms involve genetics, lifestyle or dietary choices? If one could identify the mechanisms involved, future research would have targets to extend lifespan and improve the "healthspan" of the human race.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ovarian derived exosomal miRNA as a juvenile protective factors
-
批准号:10674254
-
项目类别:
-
资助金额:$28.66万
-
财政年份:2022
-
负责人:MICHAL Mateusz MASTERNAK
-
依托单位:
Role of adipose tissue cellular composition on healthy metabolism
-
批准号:10046434
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2019
-
负责人:MICHAL Mateusz MASTERNAK
-
依托单位:
Role of GH/IGF1 signaling pathway on pro-longevity miRNAs
-
批准号:9581485
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2018
-
负责人:MICHAL Mateusz MASTERNAK
-
依托单位:
Dietary fat, visceral fat depots and aging
-
批准号:8325546
-
项目类别:
-
资助金额:$28.13万
-
财政年份:2010
-
负责人:MICHAL Mateusz MASTERNAK
-
依托单位:
Dietary fat, visceral fat depots and aging
-
批准号:8149819
-
项目类别:
-
资助金额:$28.16万
-
财政年份:2010
-
负责人:MICHAL Mateusz MASTERNAK
-
依托单位:
Dietary fat, visceral fat depots and aging
-
批准号:8728532
-
项目类别:
-
资助金额:$8.76万
-
财政年份:2010
-
负责人:MICHAL Mateusz MASTERNAK
-
依托单位:
Dietary fat, visceral fat depots and aging
-
批准号:8536984
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2010
-
负责人:MICHAL Mateusz MASTERNAK
-
依托单位:
Dietary fat, visceral fat depots and aging
-
批准号:8720641
-
项目类别:
-
资助金额:$28.06万
-
财政年份:2010
-
负责人:MICHAL Mateusz MASTERNAK
-
依托单位:
Dietary fat, visceral fat depots and aging
-
批准号:8520130
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2010
-
负责人:MICHAL Mateusz MASTERNAK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HPV通过C/EBPβ/miR-31/FAT4轴调控宫颈癌发生的机制研究
-
批准号:2026JJ80038
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘伟
-
依托单位:
FAT1缺失上调CUL4A介导肺鳞癌化疗抵抗的机制研究
-
批准号:QN25H160122
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘盼
-
依托单位:
类泛素蛋白FAT10通过促进CSTF2诱导PD-L1 3'UTR缩短介导肿瘤免疫逃逸的机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:邵江华
-
依托单位:
FAT4调控骨髓微环境中CD100介导多发性骨髓瘤卡非佐米耐药的
机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张丽娜
-
依托单位:
FAT1 基因突变通过增强 DNA 修复蛋白的活性导致头颈鳞状
细胞癌耐药的机制研究
-
批准号:2024JJ9556
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:罗昰
-
依托单位:
UBE2C介导FAT1泛素化类型串扰诱导CD8+T细胞耗竭促进膀胱癌淋巴转移的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:黄华生
-
依托单位:
IL-32通过FAT4介导调控Hippo/YAP信号通路在椎间盘退变中的作用及机制研究
-
批准号:82302737
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:邱贤健
-
依托单位:
类泛素蛋白FAT10通过AMPK信号通路诱导自噬在乳腺癌他莫昔芬耐药中的作用及机制研究
-
批准号:82360602
-
项目类别:地区科学基金项目
-
资助金额:31.00万元
-
批准年份:2023
-
负责人:邹玉峰
-
依托单位:
CaMKII介导FAT/CD36调控衰老心肌脂毒性损伤的机制研究
-
批准号:82300334
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:孟一迪
-
依托单位:
肿瘤抑制因子FAT4负调控β-catenin激活抗宫颈癌免疫反应的机制研究
-
批准号:82303141
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王东营
-
依托单位: